GALT
Galectin Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.09
-0.07 ▼ -2.22%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$3.09
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -0.59 | Insider Own | 29.35% | Shs Outstand | 0.06B | Perf Week | -0.32% |
| Market Cap | 0.20B | Forward P/E | - | EPS next Y | 16.33% | Insider Trans | -5.17% | Shs Float | 0.05B | Perf Month | 11.96% |
| Enterprise Value | 0.31B | PEG | - | EPS next Q | -0.1 | Inst Own | 18.02% | Short Float | 11.35% | Perf Quarter | -43.72% |
| Income | -0.04B | P/S | - | EPS this Y | 35.53% | Inst Trans | 3.33% | Short Ratio | 11.05 | Perf Half Y | -47.98% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 16.03% | ROA | -178.33% | Short Interest | 5.17M | Perf YTD | -25.72% |
| Book/sh | -1.95 | P/C | 17.28 | EPS past 3/5Y | -13.03% -23.89% | ROE | - | 52W High | -56.66% ($7.13) | Perf Year | 75.57% |
| Cash/sh | 0.18 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 175.89% ($1.12) | Perf 3Y | 69.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 18.82% | Gross Margin | - | Volatility(W/M) | 11.03% 7.71% | Perf 5Y | 33.77% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.25 | Perf 10Y | 104.64% |
| Dividend Ex-Date | - | Quick Ratio | 0.09 | EPS Q/Q | 28.99% | Profit Margin | - | RSI (14) | 49.49 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.09 | Sales Q/Q | - | SMA20 | 1.81% ($3.04) | Beta | 0.99 | Target Price | $11 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -0.68% ($3.11) | Rel Volume | 0.59 | Prev Close | $3.16 |
| Employees | 15 | LT Debt/Eq | - | EPS/Sales Surpr. | -18.18% - | SMA200 | -19.73% ($3.85) | Avg Volume(3M) | 0.47M | Price | $3.09 |
| IPO | 2002/9/4 | Option/Short | Yes/Yes | Trades | 3549 | Volume | 277,426 | Change | -2.22% |
뉴스 로딩 중...